2022
DOI: 10.1038/s41371-022-00659-z
|View full text |Cite
|
Sign up to set email alerts
|

HEARTS in the Americas: a global example of using clinically validated automated blood pressure devices in cardiovascular disease prevention and management in primary health care settings

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0
4

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 19 publications
(14 citation statements)
references
References 13 publications
0
10
0
4
Order By: Relevance
“…The traditional model does not emphasize enough the quality of blood pressure measurement for screening, diagnosis, and treatment, which consequently leads to over- or under-treatment of hypertension. Therefore, to increase accuracy in the measurement of blood pressure, HEARTS adopted a standardized technique and recommends regular training on this technique for members of the health care team so they perform the task accurately ( 19 ) and the exclusive use of clinically validated automated blood pressure measuring devices ( 20 ).…”
Section: Hearts In the Americas Initiative: Background And Salient El...mentioning
confidence: 99%
See 1 more Smart Citation
“…The traditional model does not emphasize enough the quality of blood pressure measurement for screening, diagnosis, and treatment, which consequently leads to over- or under-treatment of hypertension. Therefore, to increase accuracy in the measurement of blood pressure, HEARTS adopted a standardized technique and recommends regular training on this technique for members of the health care team so they perform the task accurately ( 19 ) and the exclusive use of clinically validated automated blood pressure measuring devices ( 20 ).…”
Section: Hearts In the Americas Initiative: Background And Salient El...mentioning
confidence: 99%
“…HEARTS in the Americas has developed a set of strategic actions and produced practical resources to address these essential issues ( 20 ), including communication and education materials to increase advocacy, awareness, training, and certification of PHC teams, and a guidance document to help countries to strengthen their regulatory frameworks and procurement process to ensure the exclusive use of clinically validated automated BPMD ( 38 ). Accordingly, many PHC facilities implementing HEARTS have prioritized both the training and certification of their personnel in correct blood pressure measurement and the use of validated automated BPMD ( 38 – 40 ) ( Table 3 ).…”
Section: Innovating With Hearts In the Americasmentioning
confidence: 99%
“…El modelo tradicional no le da suficiente prioridad a la calidad de la medición de la presión arterial para la detección, el diagnóstico y el tratamiento, lo que conduce a un tratamiento excesivo o insuficiente de la hipertensión. Por lo tanto, para aumentar la exactitud de la medición de la presión arterial, HEARTS adoptó una técnica estandarizada y recomienda que los miembros del equipo de atención médica reciban en forma regular cursos de capacitación para que realicen la tarea con precisión ( 19 ), así como el uso exclusivo de dispositivos automatizados de medición de la presión arterial validados clínicamente ( 20 ).…”
Section: Iniciativa Hearts En Las Américas: Antecedentes Y Elementos ...unclassified
“…HEARTS en las Américas ha desarrollado un conjunto de acciones estratégicas y producido recursos prácticos para abordar estos temas esenciales ( 20 ). Estos elementos incluyen materiales educativos y de comunicación para aumentar la promoción, la concientización, la capacitación y la certificación de los equipos de APS, así como un documento de orientación para ayudar a los países a fortalecer sus marcos regulatorios y procesos de compra para garantizar el uso exclusivo de DMPA automatizados y clínicamente validados ( 38 ).…”
Section: Innovar Con Hearts En Las Américasunclassified
“…The resulting document [14] is a tool to be used by Ministries of Health and national regulatory authorities to develop, implement and enforce regulations for the exclusive premarket approval of validated automated BPMDs. During this process, a strategy was developed to systematize the work being conducted at the country level, with the technical cooperation by PAHO, to achieve the goal of exclusive use of validated automated BPMDs, which is comprised by several elements [15], as seen in Box 1.…”
Section: Introductionmentioning
confidence: 99%